To protect and modify double-stranded RNA – the critical roles of ADARs in development, immunity and oncogenesis

References

• Ahmad S, Mu X, Yang F, Greenwald E, Park JW, Jacob E, Zhang CZ, Hur S. 2018. Breaching self-tolerance to Alu duplex RNA underlies MDA5-mediated inflammation. Cell. 172(4):797–810 e13.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell. 124:783–801.
   PubMed Web of Science ®Google Scholar
• Albertin CB, Simakov O, Mitros T, Wang ZY, Pungor JR, Edsinger-Gonzales E, Brenner S, Ragsdale CW, Rokhsar DS. 2015. The octopus genome and the evolution of cephalopod neural and morphological novelties. Nature. 524:220–224.
   PubMed Web of Science ®Google Scholar
• Alon S, Garrett SC, Levanon EY, Olson S, Graveley BR, Rosenthal JJ, Eisenberg E. 2015. The majority of transcripts in the squid nervous system are extensively recoded by A-to-I RNA editing. Elife. 4:e05198.
   Web of Science ®Google Scholar
• Aquino-Jarquin G. 2020. Novel engineered programmable systems for ADAR-mediated RNA editing. Mol Ther Nucleic Acids. 19:1065–1072.
   PubMedGoogle Scholar
• Athanasiadis A, Rich A, Maas S. 2004. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLOS Biol. 2:e391.
   PubMed Web of Science ®Google Scholar
• Bahn JH, Ahn J, Lin X, Zhang Q, Lee JH, Civelek M, Xiao X. 2015. Genomic analysis of ADAR1 binding and its involvement in multiple RNA processing pathways. Nat Commun. 6:6355.
   PubMed Web of Science ®Google Scholar
• Bajad P, Ebner F, Amman F, Szabo B, Kapoor U, Manjali G, Hildebrandt A, Janisiw MP, Jantsch MF. 2020. An internal deletion of ADAR rescued by MAVS deficiency leads to a minute phenotype. Nucleic Acids Res. 48:3286–3303.
   PubMed Web of Science ®Google Scholar
• Barak M, Porath HT, Finkelstein G, Knisbacher BA, Buchumenski I, Roth SH, Levanon EY, Eisenberg E. 2020. Purifying selection of long dsRNA is the first line of defense against false activation of innate immunity. Genome Biol. 21:26.
   PubMed Web of Science ®Google Scholar
• Barraud P, Banerjee S, Mohamed WI, Jantsch MF, Allain FH. 2014. A bimodular nuclear localization signal assembled via an extended double-stranded RNA-binding domain acts as an RNA-sensing signal for transportin 1. Proc Natl Acad Sci USA. 111:E1852–61.
   PubMed Web of Science ®Google Scholar
• Beghini A, Ripamonti CB, Peterlongo P, Roversi G, Cairoli R, Morra E, Larizza L. 2000. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum Mol Genet. 9:2297–2304.
   PubMed Web of Science ®Google Scholar
• Berger I, Winston W, Manoharan R, Schwartz T, Alfken J, Kim YG, Lowenhaupt K, Herbert A, Rich A. 1998. Spectroscopic characterization of a DNA-binding domain, Z alpha, from the editing enzyme, dsRNA adenosine deaminase: evidence for left-handed Z-DNA in the Z alpha-DNA complex. Biochemistry. 37:13313–13321.
   PubMed Web of Science ®Google Scholar
• Bhalla T, Rosenthal JJ, Holmgren M, Reenan R. 2004. Control of human potassium channel inactivation by editing of a small mRNA hairpin. Nat Struct Mol Biol. 11:950–956.
   PubMed Web of Science ®Google Scholar
• Blow MJ, Grocock RJ, van Dongen S, Enright AJ, Dicks E, Futreal PA, Wooster R, Stratton MR. 2006. RNA editing of human microRNAs. Genome Biol. 7:R27.
   PubMed Web of Science ®Google Scholar
• Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, Emeson RB. 1997. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 387:303–308.
   PubMed Web of Science ®Google Scholar
• Bycroft M, Grunert S, Murzin AG, Proctor M, St Johnston D. 1995. NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5. Embo J. 14:3563–3571.
   PubMed Web of Science ®Google Scholar
• Capshew CR, Dusenbury KL, Hundley HA. 2012. Inverted Alu dsRNA structures do not affect localization but can alter translation efficiency of human mRNAs independent of RNA editing. Nucleic Acids Res. 40:8637–8645.
   PubMed Web of Science ®Google Scholar
• Cenci C, Barzotti R, Galeano F, Corbelli S, Rota R, Massimi L, Di Rocco C, O'Connell MA, Gallo A. 2008. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem. 283:7251–7260.
   PubMed Web of Science ®Google Scholar
• Cesarini V, Silvestris DA, Tassinari V, Tomaselli S, Alon S, Eisenberg E, Locatelli F, Gallo A. 2018. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion. Nucleic Acids Res. 46(4):2045–2059.
   PubMed Web of Science ®Google Scholar
• Chalk AM, Taylor S, Heraud-Farlow JE, Walkley CR. 2019. The majority of A-to-I RNA editing is not required for mammalian homeostasis. Genome Biol. 20:268.
   PubMed Web of Science ®Google Scholar
• Chan TH, Lin CH, Qi L, Fei J, Li Y, Yong KJ, Liu M, Song Y, Chow RK, Ng VH, et al. 2014. A disrupted RNA editing balance mediated by ADARs (adenosine deaminases that act on RNA) in human hepatocellular carcinoma. Gut. 63:832–843.
   PubMed Web of Science ®Google Scholar
• Chan TH, Qamra A, Tan KT, Guo J, Yang H, Qi L, Lin JS, Ng VH, Song Y, Hong H, et al. 2016. ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer. Gastroenterology. 151(4):637–650 e10.
   PubMed Web of Science ®Google Scholar
• Chen CX, Cho DS, Wang Q, Lai F, Carter KC, Nishikura K. 2000. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single- and double-stranded RNA binding domains. RNA. 6:755–767.
   PubMed Web of Science ®Google Scholar
• Chen L, Li Y, Lin CH, Chan TH, Chow RK, Song Y, Liu M, Yuan YF, Fu L, Kong KL, et al. 2013. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med. 19:209–216.
   PubMed Web of Science ®Google Scholar
• Chen LL, Carmichael GG. 2009. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell. 35:467–478.
   PubMed Web of Science ®Google Scholar
• Chen LL, Yang L. 2017. ALUternative regulation for gene expression. Trends Cell Biol. 27:480–490.
   PubMed Web of Science ®Google Scholar
• Chen YB, Liao XY, Zhang JB, Wang F, Qin HD, Zhang L, Shugart YY, Zeng YX, Jia WH. 2017. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma. Int J Oncol. 50:622–630.
   PubMed Web of Science ®Google Scholar
• Choudhury Y, Tay FC, Lam DH, Sandanaraj E, Tang C, Ang BT, Wang S. 2012. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells. J Clin Invest. 122(11):4059–4076.
   PubMed Web of Science ®Google Scholar
• Chung H, Calis JJA, Wu X, Sun T, Yu Y, Sarbanes SL, Dao Thi VL, Shilvock AR, Hoffmann HH, Rosenberg BR, et al. 2018. Human ADAR1 prevents endogenous RNA from triggering translational shutdown. Cell. 172(4):811–824 e14.
   PubMed Web of Science ®Google Scholar
• Crow Y, Keshavan N, Barbet JP, Bercu G, Bondet V, Boussard C, Dedieu N, Duffy D, Hully M, Giardini A, et al. 2020. Cardiac valve involvement in ADAR-related type I interferonopathy. J Med Genet. 57(7):475–478.
   PubMed Web of Science ®Google Scholar
• Deffit SN, Hundley HA. 2016. To edit or not to edit: regulation of ADAR editing specificity and efficiency. Wiley Interdiscip Rev RNA. 7:113–127.
   PubMed Web of Science ®Google Scholar
• Deffit SN, Yee BA, Manning AC, Rajendren S, Vadlamani P, Wheeler EC, Domissy A, Washburn MC, Yeo GW, Hundley HA. 2017. The C. elegans neural editome reveals an ADAR target mRNA required for proper chemotaxis. Elife. 6:e28625.
   PubMed Web of Science ®Google Scholar
• Deng P, Khan A, Jacobson D, Sambrani N, McGurk L, Li X, Jayasree A, Hejatko J, Shohat-Ophir G, O'Connell MA, et al. 2020. Adar RNA editing-dependent and -independent effects are required for brain and innate immune functions in Drosophila. Nat Commun. 11:1580.
   PubMed Web of Science ®Google Scholar
• Dexheimer PJ, Cochella L. 2020. MicroRNAs: from mechanism to organism. Front Cell Dev Biol. 8:409.
   PubMed Web of Science ®Google Scholar
• Di Meglio P, Villanova F, Nestle FO. 2014. Psoriasis. Cold Spring Harb Perspect Med. 4(8):a015354.
   PubMed Web of Science ®Google Scholar
• Doyle M, Jantsch MF. 2002. New and old roles of the double-stranded RNA-binding domain. J Struct Biol. 140:147–153.
   PubMed Web of Science ®Google Scholar
• Doyle M, Jantsch MF. 2003. Distinct in vivo roles for double-stranded RNA-binding domains of the Xenopus RNA-editing enzyme ADAR1 in chromosomal targeting. J Cell Biol. 161:309–319.
   PubMed Web of Science ®Google Scholar
• Ekdahl Y, Farahani HS, Behm M, Lagergren J, Öhman M. 2012. A-to-I editing of microRNAs in the mammalian brain increases during development. Genome Res. 22:1477–1487.
   PubMed Web of Science ®Google Scholar
• Elbarbary RA, Li W, Tian B, Maquat LE. 2013. STAU1 binding 3' UTR IRAlus complements nuclear retention to protect cells from PKR-mediated translational shutdown. Genes Dev. 27:1495–1510.
   PubMed Web of Science ®Google Scholar
• Fischer SEJ, Ruvkun G. 2020. Caenorhabditis elegans ADAR editing and the ERI-6/7/MOV10 RNAi pathway silence endogenous viral elements and LTR retrotransposons. Proc Natl Acad Sci USA. 117:5987–5996.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick T, Huang S. 2012. 3'-UTR-located inverted Alu repeats facilitate mRNA translational repression and stress granule accumulation. Nucleus. 3:359–369.
   PubMed Web of Science ®Google Scholar
• Fritz J, Strehblow A, Taschner A, Schopoff S, Pasierbek P, Jantsch MF. 2009. RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol Cell Biol. 29:1487–1497.
   PubMed Web of Science ®Google Scholar
• Fritzell K, Xu LD, Lagergren J, Ohman M. 2018. ADARs and editing: the role of A-to-I RNA modification in cancer progression. Semin Cell Dev Biol. 79:123–130.
   PubMed Web of Science ®Google Scholar
• Fu L, Qin YR, Ming XY, Zuo XB, Diao YW, Zhang LY, Ai J, Liu BL, Huang TX, Cao TT, Tan BB, et al. 2017. RNA editing of SLC22A3 drives early tumor invasion and metastasis in familial esophageal cancer. Proc Natl Acad Sci USA. 114(23):E4631–E40.
   PubMed Web of Science ®Google Scholar
• Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. 2008. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 28:5369–5380.
   PubMed Web of Science ®Google Scholar
• Gacem N, Kavo A, Zerad L, Richard L, Mathis S, Kapur RP, Parisot M, Amiel J, Dufour S, de la Grange P, et al. 2020. ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development. Nat Commun. 11:198.
   PubMed Web of Science ®Google Scholar
• Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafre SA, Farace MG. 2007. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem. 282:23716–23724.
   PubMed Web of Science ®Google Scholar
• Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M, Boldrini R, Massimi L, Di Rocco CM, Locatelli F, et al. 2013. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene. 32:998–1009.
   PubMed Web of Science ®Google Scholar
• Galipon J, Ishii R, Suzuki Y, Tomita M, Ui-Tei K. 2017. Differential binding of three major human ADAR isoforms to coding and long non-coding transcripts. Genes. 8(2):68.
   Web of Science ®Google Scholar
• Gallo A, Keegan LP, Ring GM, O'Connell MA. 2003. An ADAR that edits transcripts encoding ion channel subunits functions as a dimer. Embo J. 22:3421–3430.
   PubMed Web of Science ®Google Scholar
• Gammon DB, Mello CC. 2015. RNA interference-mediated antiviral defense in insects. Curr Opin Insect Sci. 8:111–120.
   PubMed Web of Science ®Google Scholar
• Ganem NS, Ben-Asher N, Lamm AT. 2017. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic. Drug Resist Updat. 32:16–22.
   PubMed Web of Science ®Google Scholar
• Ganem NS, Ben-Asher N, Manning AC, Deffit SN, Washburn MC, Wheeler EC, Yeo GW, Zgayer OB, Mantsur E, Hundley HA, et al. 2019. Disruption in A-to-I editing levels affects C. elegans development more than a complete lack of editing. Cell Rep. 27(4):1244–1253 e4.
   PubMed Web of Science ®Google Scholar
• Gannon HS, Zou T, Kiessling MK, Gao GF, Cai D, Choi PS, Ivan AP, Buchumenski I, Berger AC, Goldstein JT, et al. 2018. Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells. Nat Commun. 9:5450.
   PubMed Web of Science ®Google Scholar
• Gantier MP, Williams BR. 2007. The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev. 18:363–371.
   PubMed Web of Science ®Google Scholar
• George CX, Samuel CE. 1999. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc Natl Acad Sci USA. 96:4621–4626.
   PubMed Web of Science ®Google Scholar
• Gerber A, O'Connell MA, Keller W. 1997. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA. 3:453–463.
   PubMed Web of Science ®Google Scholar
• Gleghorn ML, Maquat LE. 2014. Black sheep' that don't leave the double-stranded RNA-binding domain fold. Trends Biochem Sci. 39:328–340.
   PubMed Web of Science ®Google Scholar
• Goodman RA, Macbeth MR, Beal PA. 2012. ADAR proteins: structure and catalytic mechanism. Curr Top Microbiol Immunol. 353:1–33.
   PubMed Web of Science ®Google Scholar
• Graveley BR, Brooks AN, Carlson JW, Duff MO, Landolin JM, Yang L, Artieri CG, van Baren MJ, Boley N, Booth BW, et al. 2011. The developmental transcriptome of Drosophila melanogaster. Nature. 471:473–479.
   PubMed Web of Science ®Google Scholar
• Greenberger S, Levanon EY, Paz-Yaacov N, Barzilai A, Safran M, Osenberg S, Amariglio N, Rechavi G, Eisenberg E. 2010. Consistent levels of A-to-I RNA editing across individuals in coding sequences and non-conserved Alu repeats. BMC Genomics. 11:608.
   PubMed Web of Science ®Google Scholar
• Grice LF, Degnan BM. 2015. The origin of the ADAR gene family and animal RNA editing. BMC Evol Biol. 15:4.
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Li A, Kossenkov AV, Sakurai M, Yan J, Li Y, Xu H, Wang J, Zhang PJ, Zhang L, et al. 2016. The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis. Nat Commun. 7:10715.
   PubMed Web of Science ®Google Scholar
• Han J, An O, Hong H, Chan THM, Song Y, Shen H, Tang SJ, Lin JS, Ng VHE, Tay DJT, et al. 2020. Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression. Sci Adv. 6:eaba5136.
   PubMed Web of Science ®Google Scholar
• Han L, Diao L, Yu S, Xu X, Li J, Zhang R, Yang Y, Werner HMJ, Eterovic AK, Yuan Y, et al. 2015. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell. 28:515–528.
   PubMed Web of Science ®Google Scholar
• Han SW, Kim HP, Shin JY, Jeong EG, Lee WC, Kim KY, Park SY, Lee DW, Won JK, Jeong SY, et al. 2014. RNA editing in RHOQ promotes invasion potential in colorectal cancer. J Exp Med. 211(4):613–621.
   PubMed Web of Science ®Google Scholar
• Hartner JC, Schmittwolf C, Kispert A, Müller AM, Higuchi M, Seeburg PH. 2004. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J Biol Chem. 279:4894–4902.
   PubMed Web of Science ®Google Scholar
• Hartner JC, Walkley CR, Lu J, Orkin SH. 2009. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat Immunol. 10:109–115.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Suzuki T. 2013. Dyschromatosis symmetrica hereditaria. J Dermatol. 40:336–343.
   PubMed Web of Science ®Google Scholar
• Helwak A, Tollervey D. 2014. Mapping the miRNA interactome by cross-linking ligation and sequencing of hybrids (CLASH). Nat Protoc. 9:711–728.
   PubMed Web of Science ®Google Scholar
• Heraud-Farlow JE, Chalk AM, Linder SE, Li Q, Taylor S, White JM, Pang L, Liddicoat BJ, Gupte A, Li JB, et al. 2017. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis. Genome Biol. 18:166.
   PubMed Web of Science ®Google Scholar
• Herbert A, Alfken J, Kim YG, Mian IS, Nishikura K, Rich A. 1997. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proc Natl Acad Sci USA. 94:8421–8426.
   PubMed Web of Science ®Google Scholar
• Higuchi M, Maas S, Single FN, Hartner J, Rozov A, Burnashev N, Feldmeyer D, Sprengel R, Seeburg PH. 2000. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature. 406:78–81.
   PubMed Web of Science ®Google Scholar
• Hoopengardner B, Bhalla T, Staber C, Reenan R. 2003. Nervous system targets of RNA editing identified by comparative genomics. Science. 301(5634):832–836.
   PubMed Web of Science ®Google Scholar
• Hough RF, Lingam AT, Bass BL. 1999. Caenorhabditis elegans mRNAs that encode a protein similar to ADARs derive from an operon containing six genes. Nucleic Acids Res. 27(17):3424–3432.
   PubMed Web of Science ®Google Scholar
• Hsiao YE, Bahn JH, Yang Y, Lin X, Tran S, Yang EW, Quinones-Valdez G, Xiao X. 2018. RNA editing in nascent RNA affects pre-mRNA splicing. Genome Res. 28(6):812–823.
   PubMed Web of Science ®Google Scholar
• Hu X, Chen J, Shi X, Feng F, Lau KW, Chen Y, Chen Y, Jiang L, Cui F, Zhang Y, et al. 2017. RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers. Tumour Biol. 39(8):1010428317700001
   Google Scholar
• Hu X, Wan S, Ou Y, Zhou B, Zhu J, Yi X, Guan Y, Jia W, Liu X, Wang Q, et al. 2015. RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing. Cancer Lett. 357(2):510–519.
   PubMed Web of Science ®Google Scholar
• Hundley HA, Krauchuk AA, Bass BL. 2008. C. elegans and H. sapiens mRNAs with edited 3' UTRs are present on polysomes. RNA. 14:2050–2060.
   PubMed Web of Science ®Google Scholar
• Hung T, Pratt GA, Sundararaman B, Townsend MJ, Chaivorapol C, Bhangale T, Graham RR, Ortmann W, Criswell LA, Yeo GW, et al. 2015. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science. 350:455–459.
   PubMed Web of Science ®Google Scholar
• Hur S. 2019. Double-stranded RNA sensors and modulators in innate immunity. Annu Rev Immunol. 37:349–375.
   PubMed Web of Science ®Google Scholar
• Ingleby L, Maloney R, Jepson J, Horn R, Reenan R. 2009. Regulated RNA editing and functional epistasis in Shaker potassium channels. J Gen Physiol. 133:17–27.
   PubMed Web of Science ®Google Scholar
• Ishizuka JJ, Manguso RT, Cheruiyot CK, Bi K, Panda A, Iracheta-Vellve A, Miller BC, Du PP, Yates KB, Dubrot J, Buchumenski I, Comstock DE, et al. 2019. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature. 565:43–48.
   PubMed Web of Science ®Google Scholar
• Jacobs BL, Langland JO. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology. 219:339–349.
   PubMed Web of Science ®Google Scholar
• Jain M, Jantsch MF, Licht K. 2019. The Editor's I on Disease Development. Trends Genet. 35:903–913.
   PubMed Web of Science ®Google Scholar
• Jiang T, Shi T, Zhang H, Hu J, Song Y, Wei J, Ren S, Zhou C. 2019. Tumor neoantigens: from basic research to clinical applications. J Hematol Oncol. 12:93.
   PubMed Web of Science ®Google Scholar
• Kapoor U, Licht K, Amman F, Jakobi T, Martin D, Dieterich C, Jantsch MF. 2020. ADAR-deficiency perturbs the global splicing landscape in mouse tissues. Genome Res. 30:1107–1118.
   PubMed Web of Science ®Google Scholar
• Katrekar D, Chen G, Meluzzi D, Ganesh A, Worlikar A, Shih YR, Varghese S, Mali P. 2019. In vivo RNA editing of point mutations via RNA-guided adenosine deaminases. Nat Methods. 16:239–242.
   PubMed Web of Science ®Google Scholar
• Kawahara Y, Zinshteyn B, Chendrimada TP, Shiekhattar R, Nishikura K. 2007. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 8:763–769.
   PubMed Web of Science ®Google Scholar
• Kawahara Y, Zinshteyn B, Sethupathy P, Iizasa H, Hatzigeorgiou AG, Nishikura K. 2007. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 315:1137–1140.
   PubMed Web of Science ®Google Scholar
• Keegan LP, McGurk L, Palavicini JP, Brindle J, Paro S, Li X, Rosenthal JJ, O'Connell MA. 2011. Functional conservation in human and drosophila of metazoan ADAR2 involved in RNA editing: loss of ADAR1 in insects. Nucleic Acids Res. 39:7249–7262.
   PubMed Web of Science ®Google Scholar
• Keppler A, Gendreizig S, Gronemeyer T, Pick H, Vogel H, Johnsson K. 2003. A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat Biotechnol. 21:86–89.
   PubMed Web of Science ®Google Scholar
• Khan A, Paro S, McGurk L, Sambrani N, Hogg MC, Brindle J, Pennetta G, Keegan LP, O'Connell MA. 2020. Membrane and synaptic defects leading to neurodegeneration in ADAR mutant drosophila are rescued by increased autophagy. BMC Biol. 18:15.
   PubMed Web of Science ®Google Scholar
• Kim DD, Kim TT, Walsh T, Kobayashi Y, Matise TC, Buyske S, Gabriel A. 2004. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 14:1719–1725.
   PubMed Web of Science ®Google Scholar
• Knight SW, Bass BL. 2002. The role of RNA editing by ADARs in RNAi. Mol Cell. 10:809–817.
   PubMed Web of Science ®Google Scholar
• Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, et al. 1998. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol. 152:1107–1123.
   PubMed Web of Science ®Google Scholar
• Kondo T, Suzuki T, Mitsuhashi Y, Ito S, Kono M, Komine M, Akita H, Tomita Y. 2008. Six novel mutations of the ADAR1 gene in patients with dyschromatosis symmetrica hereditaria: histological observation and comparison of genotypes and clinical phenotypes. J Dermatol. 35:395–406.
   PubMed Web of Science ®Google Scholar
• Kong XY, Vik ES, Nawaz MS, Berges N, Dahl TB, Vågbø C, Suganthan R, Segers F, Holm S, Quiles-Jiménez A, et al. 2020. Deletion of Endonuclease V suppresses chemically induced hepatocellular carcinoma. Nucleic Acids Res. 48:4463–4479.
   PubMed Web of Science ®Google Scholar
• Kono M, Suganuma M, Akiyama M, Ito Y, Ujiie H, Morimoto K. 2014. Novel ADAR1 mutations including a single amino acid deletion in the deaminase domain underlie dyschromatosis symmetrica hereditaria in Japanese families. Int J Dermatol. 53:e194-6.
   PubMed Web of Science ®Google Scholar
• Krovat BC, Jantsch MF. 1996. Comparative mutational analysis of the double-stranded RNA binding domains of Xenopus laevis RNA-binding protein A. J Biol Chem. 271:28112–28119.
   PubMed Web of Science ®Google Scholar
• Kung CP, Cottrell KA, Ryu S, Bramel ER, Kladney RD, Bao EA, Freeman EC, Sabloak T, Maggi L, Jr., Weber JD. 2020. Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Oncogene.
   Web of Science ®Google Scholar
• Kuttan A, Bass BL. 2012. Mechanistic insights into editing-site specificity of ADARs. Proc Natl Acad Sci USA. 109:E3295–E3304.
   PubMed Web of Science ®Google Scholar
• Lai F, Drakas R, Nishikura K. 1995. Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamate-gated ion channel transcripts. J Biol Chem. 270:17098–17105.
   PubMed Web of Science ®Google Scholar
• Lai ML, Yang LJ, Zhu XH, Li M. 2012. A novel mutation of the DSRAD gene in a Chinese family with dyschromatosis symmetrica hereditaria. Genet Mol Res. 11:1731–1737.
   PubMed Web of Science ®Google Scholar
• Lamers MM, van den Hoogen BG, Haagmans BL. 2019. ADAR1: "editor-in-chief" of cytoplasmic innate immunity. Front Immunol. 10:1763.
   PubMed Web of Science ®Google Scholar
• Lazzari E, Mondala PK, Santos ND, Miller AC, Pineda G, Jiang Q, Leu H, Ali SA, Ganesan AP, Wu CN, et al. 2017. Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma. Nat Commun. 8(1):1922
   PubMedGoogle Scholar
• Lehmann KA, Bass BL. 1999. The importance of internal loops within RNA substrates of ADAR1. J Mol Biol. 291(1):1–13.
   PubMed Web of Science ®Google Scholar
• Lev-Maor G, Sorek R, Levanon EY, Paz N, Eisenberg E, Ast G. 2007. RNA-editing-mediated exon evolution. Genome Biol. 8:R29.
   PubMed Web of Science ®Google Scholar
• Levanon EY, Eisenberg E, Yelin R, Nemzer S, Hallegger M, Shemesh R, Fligelman ZY, Shoshan A, Pollock SR, Sztybel D, Olshansky M, et al. 2004. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat Biotechnol. 22(8):1001–1005.
   PubMed Web of Science ®Google Scholar
• Li B, Han Q, Zhu Y, Yu Y, Wang J, Jiang X. 2012. Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. Febs J. 279(13):2393–2398.
   PubMed Web of Science ®Google Scholar
• Liu WH, Chen CH, Yeh KH, Li CL, Wu YJ, Chen DS, Chen PJ, Yeh SH. 2013. ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers. PLoS One. 8(12):e81922
   PubMed Web of Science ®Google Scholar
• Liang H, Landweber LF. 2007. Hypothesis: RNA editing of microRNA target sites in humans? RNA. 13:463–467.
   PubMed Web of Science ®Google Scholar
• Licht K, Hartl M, Amman F, Anrather D, Janisiw MP, Jantsch MF. 2019. Inosine induces context-dependent recoding and translational stalling. Nucleic Acids Res. 47:3–14.
   PubMed Web of Science ®Google Scholar
• Licht K, Kapoor U, Amman F, Picardi E, Martin D, Bajad P, Jantsch MF. 2019. A high resolution A-to-I editing map in the mouse identifies editing events controlled by pre-mRNA splicing. Genome Res. 29(9):1453–1463.
   PubMed Web of Science ®Google Scholar
• Liddicoat BJ, Chalk AM, Walkley CR. 2016. ADAR1, inosine and the immune sensing system: distinguishing self from non-self. Wiley Interdiscip Rev RNA. 7:157–172.
   PubMed Web of Science ®Google Scholar
• Liddicoat BJ, Piskol R, Chalk AM, Ramaswami G, Higuchi M, Hartner JC, Li JB, Seeburg PH, Walkley CR. 2015. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science. 349:1115–1120.
   PubMed Web of Science ®Google Scholar
• Liscovitch N, Bazak L, Levanon EY, Chechik G. 2014. Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain. RNA Biol. 11:1447–1456.
   PubMed Web of Science ®Google Scholar
• Liu H, Golji J, Brodeur LK, Chung FS, Chen JT, deBeaumont RS, Bullock CP, Jones MD, Kerr G, Li L, et al. 2019. Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss. Nat Med. 25:95–102.
   PubMed Web of Science ®Google Scholar
• Liu Q, Jiang L, Liu WL, Kang XJ, Ao Y, Sun M, Luo Y, Song Y, Lo WH, Zhang X. 2006. Two novel mutations and evidence for haploinsufficiency of the ADAR gene in dyschromatosis symmetrica hereditaria. Br J Dermatol. 154:636–642.
   PubMed Web of Science ®Google Scholar
• Liu Q, Wang Z, Wu Y, Cao L, Tang Q, Xing X, Ma H, Zhang S, Luo Y. 2014. Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria. BMC Med Genet. 15:69.
   PubMed Web of Science ®Google Scholar
• Liu Y, Emeson RB, Samuel CE. 1999. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J Biol Chem. 274:18351–18358.
   PubMed Web of Science ®Google Scholar
• Liu Y, Lei M, Samuel CE. 2000. Chimeric double-stranded RNA-specific adenosine deaminase ADAR1 proteins reveal functional selectivity of double-stranded RNA-binding domains from ADAR1 and protein kinase PKR. Proc Natl Acad Sci USA. 97:12541–12546.
   PubMed Web of Science ®Google Scholar
• Liu Y, Samuel CE. 1996. Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase. J Virol. 70:1961–1968.
   PubMed Web of Science ®Google Scholar
• Liu Y, Samuel CE. 1999. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J Biol Chem. 274:5070–5077.
   PubMed Web of Science ®Google Scholar
• Livingston JH, Crow YJ. 2016. Neurologic phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutieres syndrome and beyond. Neuropediatrics. 47:355–360.
   PubMed Web of Science ®Google Scholar
• Livingston JH, Lin JP, Dale RC, Gill D, Brogan P, Munnich A, Kurian MA, Gonzalez-Martinez V, De Goede CG, Falconer A, Forte G, et al. 2014. A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1. J Med Genet. 51:76–82.
   PubMed Web of Science ®Google Scholar
• Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity. 34:680–692.
   PubMed Web of Science ®Google Scholar
• Maas S, Gommans WM. 2009a. Identification of a selective nuclear import signal in adenosine deaminases acting on RNA. Nucleic Acids Res. 37:5822–5829.
   PubMed Web of Science ®Google Scholar
• Maas S, Gommans WM. 2009b. Novel exon of mammalian ADAR2 extends open reading frame. PLOS One. 4:e4225.
   PubMed Web of Science ®Google Scholar
• Maas S, Melcher T, Herb A, Seeburg PH, Keller W, Krause S, Higuchi M, O'Connell MA. 1996. Structural requirements for RNA editing in glutamate receptor pre-mRNAs by recombinant double-stranded RNA adenosine deaminase. J Biol Chem. 271:12221–12226.
   PubMed Web of Science ®Google Scholar
• Maas S, Patt S, Schrey M, Rich A. 2001. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A. 98(25):14687–14692.
   PubMed Web of Science ®Google Scholar
• Mannion NM, Greenwood SM, Young R, Cox S, Brindle J, Read D, Nellaker C, Vesely C, Ponting CP, McLaughlin PJ, Jantsch MF, et al. 2014. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA. Cell Rep. 9:1482–1494.
   PubMed Web of Science ®Google Scholar
• Masliah G, Barraud P, Allain FH. 2013. RNA recognition by double-stranded RNA binding domains: a matter of shape and sequence. Cell Mol Life Sci. 70:1875–1895.
   PubMed Web of Science ®Google Scholar
• Matthews MM, Thomas JM, Zheng Y, Tran K, Phelps KJ, Scott AI, Havel J, Fisher AJ, Beal PA. 2016. Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat Struct Mol Biol. 23:426–433.
   PubMed Web of Science ®Google Scholar
• Merkle T, Merz S, Reautschnig P, Blaha A, Li Q, Vogel P, Wettengel J, Li JB, Stafforst T. 2019. Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat Biotechnol. 37:133–138.
   PubMed Web of Science ®Google Scholar
• Mizrahi RA, Schirle NT, Beal PA. 2013. Potent and selective inhibition of A-to-I RNA editing with 2'-O-methyl/locked nucleic acid-containing antisense oligoribonucleotides. ACS Chem Biol. 8:832–839.
   PubMed Web of Science ®Google Scholar
• Mladenova D, Barry G, Konen LM, Pineda SS, Guennewig B, Avesson L, Zinn R, Schonrock N, Bitar M, Jonkhout N, et al. 2018. Adar3 is involved in learning and memory in mice. Front Neurosci. 12:243.
   PubMed Web of Science ®Google Scholar
• Mohibi S, Chen X, Zhang J. 2019. Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer. Pharmacol Ther. 203:107390.
   PubMed Web of Science ®Google Scholar
• Montiel-Gonzalez MF, Diaz Quiroz JF, Rosenthal JJC. 2019. Current strategies for site-directed RNA editing using ADARs. Methods. 156:16–24.
   PubMed Web of Science ®Google Scholar
• Montiel-Gonzalez MF, Vallecillo-Viejo I, Yudowski GA, Rosenthal JJ. 2013. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci USA. 110:18285–18290.
   PubMed Web of Science ®Google Scholar
• Montiel-Gonzalez MF, Vallecillo-Viejo IC, Rosenthal JJ. 2016. An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res. 44:e157.
   PubMed Web of Science ®Google Scholar
• Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. 2017. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 23:615–635.
   PubMed Web of Science ®Google Scholar
• Nakano M, Fukami T, Gotoh S, Nakajima M. 2017. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer. J Biol Chem. 292(12):4873–4884.
   PubMed Web of Science ®Google Scholar
• Nanduri S, Carpick BW, Yang Y, Williams BR, Qin J. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. Embo J. 17:5458–5465.
   PubMed Web of Science ®Google Scholar
• Nishikura K. 2010. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 79:321–349.
   PubMed Web of Science ®Google Scholar
• Nishikura K, Yoo C, Kim U, Murray JM, Estes PA, Cash FE, Liebhaber SA. 1991. Substrate specificity of the dsRNA unwinding/modifying activity. Embo J. 10:3523–3532.
   PubMed Web of Science ®Google Scholar
• Oakes E, Anderson A, Cohen-Gadol A, Hundley HA. 2017. Adenosine deaminase that acts on RNA 3 (ADAR3) binding to glutamate receptor subunit B pre-mRNA inhibits RNA editing in glioblastoma. J Biol Chem. 292:4326–4335.
   PubMed Web of Science ®Google Scholar
• Oh DB, Kim YG, Rich A. 2002. Z-DNA-binding proteins can act as potent effectors of gene expression in vivo. Proc Natl Acad Sci USA. 99:16666–16671.
   PubMed Web of Science ®Google Scholar
• Ohlson J, Enstero M, Sjoberg BM, Ohman M. 2005. A method to find tissue-specific novel sites of selective adenosine deamination. Nucleic Acids Res. 33:e167.
   PubMed Web of Science ®Google Scholar
• Ohman M, Kallman AM, Bass BL. 2000. In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site. RNA. 6:687–697.
   PubMed Web of Science ®Google Scholar
• Ota H, Sakurai M, Gupta R, Valente L, Wulff BE, Ariyoshi K, Iizasa H, Davuluri RV, Nishikura K. 2013. ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing. Cell. 153:575–589.
   PubMed Web of Science ®Google Scholar
• Palavicini JP, Correa-Rojas RA, Rosenthal JJ. 2012. Extra double-stranded RNA binding domain (dsRBD) in a squid RNA editing enzyme confers resistance to high salt environment. J Biol Chem. 287:17754–17764.
   PubMed Web of Science ®Google Scholar
• Palavicini JP, O'Connell MA, Rosenthal JJ. 2009. An extra double-stranded RNA binding domain confers high activity to a squid RNA editing enzyme. RNA. 15:1208–1218.
   PubMed Web of Science ®Google Scholar
• Palladino MJ, Keegan LP, O'Connell MA, Reenan RA. 2000a. dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing. RNA. 6(7):1004–1018.
   PubMed Web of Science ®Google Scholar
• Palladino MJ, Keegan LP, O'Connell MA, Reenan RA. 2000b. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell. 102:437–449.
   PubMed Web of Science ®Google Scholar
• Parrish S, Fire A. 2001. Distinct roles for RDE-1 and RDE-4 during RNA interference in Caenorhabditis elegans. RNA. 7:1397–1402.
   PubMed Web of Science ®Google Scholar
• Patterson JB, Samuel CE. 1995. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol Cell Biol. 15:5376–5388.
   PubMed Web of Science ®Google Scholar
• Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, et al. 2007. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 17:1586–1595.
   PubMed Web of Science ®Google Scholar
• Paz-Yaacov N, Bazak L, Buchumenski I, Porath HT, Danan-Gotthold M, Knisbacher BA, Eisenberg E, Levanon EY. 2015. Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors. Cell Rep. 13:267–276.
   PubMed Web of Science ®Google Scholar
• Peng X, Xu X, Wang Y, Hawke DH, Yu S, Han L, Zhou Z, Mojumdar K, Jeong KJ, Labrie M, Tsang YH, et al. 2018. A-to-I RNA editing contributes to proteomic diversity in cancer. Cancer Cell. 33(5):817–828 e7.
   PubMed Web of Science ®Google Scholar
• Penn AC, Balik A, Greger IH. 2013. Steric antisense inhibition of AMPA receptor Q/R editing reveals tight coupling to intronic editing sites and splicing. Nucleic Acids Res. 41:1113–1123.
   PubMed Web of Science ®Google Scholar
• Pestal K, Funk CC, Snyder JM, Price ND, Treuting PM, Stetson DB. 2015. Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development. Immunity. 43:933–944.
   PubMed Web of Science ®Google Scholar
• Picardi E, Manzari C, Mastropasqua F, Aiello I, D'Erchia AM, Pesole G. 2015. Profiling RNA editing in human tissues: towards the inosinome Atlas. Sci Rep. 5:14941.
   PubMed Web of Science ®Google Scholar
• Pinto Y, Buchumenski I, Levanon EY, Eisenberg E. 2018. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets. Nucleic Acids Res. 46:71–82.
   PubMed Web of Science ®Google Scholar
• Polson AG, Bass BL. 1994. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. Embo J. 13:5701–5711.
   PubMed Web of Science ®Google Scholar
• Porath HT, Schaffer AA, Kaniewska P, Alon S, Eisenberg E, Rosenthal J, Levanon EY, Levy O. 2017. A-to-I RNA editing in the earliest-diverging eumetazoan phyla. Mol Biol Evol. 34:1890–1901.
   PubMed Web of Science ®Google Scholar
• Poulsen H, Jorgensen R, Heding A, Nielsen FC, Bonven B, Egebjerg J. 2006. Dimerization of ADAR2 is mediated by the double-stranded RNA binding domain. RNA. 12:1350–1360.
   PubMed Web of Science ®Google Scholar
• Poulsen H, Nilsson J, Damgaard CK, Egebjerg J, Kjems J. 2001. CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain. Mol Cell Biol. 21:7862–7871.
   PubMed Web of Science ®Google Scholar
• Prasanth KV, Prasanth SG, Xuan Z, Hearn S, Freier SM, Bennett CF, Zhang MQ, Spector DL. 2005. Regulating gene expression through RNA nuclear retention. Cell. 123:249–263.
   PubMed Web of Science ®Google Scholar
• Qin YR, Qiao JJ, Chan TH, Zhu YH, Li FF, Liu H, Fei J, Li Y, Guan XY, Chen L. 2014. Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma. Cancer Res. 74:840–851.
   PubMed Web of Science ®Google Scholar
• Quinones-Valdez G, Tran SS, Jun HI, Bahn JH, Yang EW, Zhan L, Brummer A, Wei X, Van Nostrand EL, Pratt GA, et al. 2019. Regulation of RNA editing by RNA-binding proteins in human cells. Commun Biol. 2:19.
   PubMed Web of Science ®Google Scholar
• Rajendren S, Manning AC, Al-Awadi H, Yamada K, Takagi Y, Hundley HA. 2018. A protein-protein interaction underlies the molecular basis for substrate recognition by an adenosine-to-inosine RNA-editing enzyme. Nucleic Acids Res. 46:9647–9659.
   PubMed Web of Science ®Google Scholar
• Ramirez-Moya J, Baker AR, Slack FJ, Santisteban P. 2020. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Oncogene. 39(18):3738–3753.
   PubMed Web of Science ®Google Scholar
• Ramos A, Grunert S, Adams J, Micklem DR, Proctor MR, Freund S, Bycroft M, St Johnston D, Varani G. 2000. RNA recognition by a Staufen double-stranded RNA-binding domain. Embo J. 19:997–1009.
   PubMed Web of Science ®Google Scholar
• Reich DP, Tyc KM, Bass BL. 2018. C. elegans ADARs antagonize silencing of cellular dsRNAs by the antiviral RNAi pathway. Genes Dev. 32:271–282.
   PubMed Web of Science ®Google Scholar
• Rice GI, Del Toro Duany Y, Jenkinson EM, Forte GM, Anderson BH, Ariaudo G, Bader-Meunier B, Baildam EM, Battini R, Beresford MW, et al. 2014. Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling. Nat Genet. 46(5):503–509.
   PubMed Web of Science ®Google Scholar
• Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, et al. 2012. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat Genet. 44:1243–1248.
   PubMed Web of Science ®Google Scholar
• Robert X, Gouet P. 2014. Deciphering key features in protein structures with the new ENDscript server. Nucleic Acids Res. 42:W320–4.
   PubMed Web of Science ®Google Scholar
• Rosenthal JJ. 2015. The emerging role of RNA editing in plasticity. J Exp Biol. 218:1812–1821.
   PubMed Web of Science ®Google Scholar
• Roth SH, Danan-Gotthold M, Ben-Izhak M, Rechavi G, Cohen CJ, Louzoun Y, Levanon EY. 2018. Increased RNA editing may provide a source for autoantigens in systemic lupus erythematosus. Cell Rep. 23:50–57.
   PubMed Web of Science ®Google Scholar
• Rueter SM, Dawson TR, Emeson RB. 1999. Regulation of alternative splicing by RNA editing. Nature. 399:75–80.
   PubMed Web of Science ®Google Scholar
• Ryter JM, Schultz SC. 1998. Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. Embo J. 17:7505–7513.
   PubMed Web of Science ®Google Scholar
• Saunders LR, Barber GN. 2003. The dsRNA binding protein family: critical roles, diverse cellular functions. FASEB J. 17:961–983.
   PubMed Web of Science ®Google Scholar
• Savva YA, Rieder LE, Reenan RA. 2012. The ADAR protein family. Genome Biol. 13:252.
   PubMed Web of Science ®Google Scholar
• Scadden AD. 2005. The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat Struct Mol Biol. 12:489–496.
   PubMed Web of Science ®Google Scholar
• Scadden AD. 2007. Inosine-containing dsRNA binds a stress-granule-like complex and downregulates gene expression in trans. Mol Cell. 28:491–500.
   PubMed Web of Science ®Google Scholar
• Scadden AD, O'Connell MA. 2005. Cleavage of dsRNAs hyper-edited by ADARs occurs at preferred editing sites. Nucleic Acids Res. 33:5954–5964.
   PubMed Web of Science ®Google Scholar
• Scadden AD, Smith CW. 2001. Specific cleavage of hyper-edited dsRNAs. Embo J. 20:4243–4252.
   PubMed Web of Science ®Google Scholar
• Schneider MF, Wettengel J, Hoffmann PC, Stafforst T. 2014. Optimal guideRNAs for re-directing deaminase activity of hADAR1 and hADAR2 in trans. Nucleic Acids Res. 42:e87.
   PubMed Web of Science ®Google Scholar
• Schoft VK, Schopoff S, Jantsch MF. 2007. Regulation of glutamate receptor B pre-mRNA splicing by RNA editing. Nucleic Acids Res. 35:3723–3732.
   PubMed Web of Science ®Google Scholar
• Sebastiani P, Montano M, Puca A, Solovieff N, Kojima T, Wang MC, Melista E, Meltzer M, Fischer SE, Andersen S, Hartley SH, et al. 2009. RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans. PLOS One. 4:e8210.
   PubMed Web of Science ®Google Scholar
• Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell. 122:669–682.
   PubMed Web of Science ®Google Scholar
• Shallev L, Kopel E, Feiglin A, Leichner GS, Avni D, Sidi Y, Eisenberg E, Barzilai A, Levanon EY, Greenberger S. 2018. Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis. RNA. 24:828–840.
   PubMed Web of Science ®Google Scholar
• Shevchenko G, Morris KV. 2018. All I's on the RADAR: role of ADAR in gene regulation. FEBS Lett. 592:2860–2873.
   PubMed Web of Science ®Google Scholar
• Shigeyasu K, Okugawa Y, Toden S, Miyoshi J, Toiyama Y, Nagasaka T, Takahashi N, Kusunoki M, Takayama T, Yamada Y, et al. 2018. AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer. JCI Insight. 3(12):e99976.
   PubMed Web of Science ®Google Scholar
• Shimokawa T, Rahman MF, Tostar U, Sonkoly E, Stahle M, Pivarcsi A, Palaniswamy R, Zaphiropoulos PG. 2013. RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. RNA Biol. 10(2):321–333.
   PubMed Web of Science ®Google Scholar
• Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME, Salameh A, Lee HJ, Kim SJ, Ivan C, et al. 2015. Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol. 17(3):311–321.
   PubMed Web of Science ®Google Scholar
• Sinnamon JR, Kim SY, Corson GM, Song Z, Nakai H, Adelman JP, Mandel G. 2017. Site-directed RNA repair of endogenous Mecp2 RNA in neurons. Proc Natl Acad Sci USA. 114:E9395–E402.
   PubMed Web of Science ®Google Scholar
• Sinnamon JR, Kim SY, Fisk JR, Song Z, Nakai H, Jeng S, McWeeney SK, Mandel G. 2020. In Vivo repair of a protein underlying a neurological disorder by programmable RNA editing. Cell Rep. 32:107878.
   PubMed Web of Science ®Google Scholar
• Slotkin W, Nishikura K. 2013. Adenosine-to-inosine RNA editing and human disease. Genome Med. 5:105.
   PubMed Web of Science ®Google Scholar
• Solomon O, Oren S, Safran M, Deshet-Unger N, Akiva P, Jacob-Hirsch J, Cesarkas K, Kabesa R, Amariglio N, Unger R, et al. 2013. Global regulation of alternative splicing by adenosine deaminase acting on RNA (ADAR). RNA. 19:591–604.
   PubMed Web of Science ®Google Scholar
• Song IH, Kim YA, Heo SH, Park IA, Lee M, Bang WS, Park HS, Gong G, Lee HJ. 2017. ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer. Tumour Biol. 39:1010428317734816.
   Google Scholar
• Song Y, Yang W, Fu Q, Wu L, Zhao X, Zhang Y, Zhang R. 2020. irCLASH reveals RNA substrates recognized by human ADARs. Nat Struct Mol Biol. 27(4):351–362.
   PubMed Web of Science ®Google Scholar
• St Johnston D, Brown NH, Gall JG, Jantsch M. 1992. A conserved double-stranded RNA-binding domain. Proc Natl Acad Sci U S A. 89:10979–10983.
   PubMed Web of Science ®Google Scholar
• St Laurent G, Tackett MR, Nechkin S, Shtokalo D, Antonets D, Savva YA, Maloney R, Kapranov P, Lawrence CE, Reenan RA. 2013. Genome-wide analysis of A-to-I RNA editing by single-molecule sequencing in Drosophila. Nat Struct Mol Biol. 20:1333–1339.
   PubMed Web of Science ®Google Scholar
• Stafforst T, Schneider MF. 2012. An RNA-deaminase conjugate selectively repairs point mutations. Angew Chem Int Ed Engl. 51:11166–11169.
   PubMed Web of Science ®Google Scholar
• Stefl R, Oberstrass FC, Hood JL, Jourdan M, Zimmermann M, Skrisovska L, Maris C, Peng L, Hofr C, Emeson RB, et al. 2010. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell. 143:225–237.
   PubMed Web of Science ®Google Scholar
• Stefl R, Xu M, Skrisovska L, Emeson RB, Allain FH. 2006. Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure. 14:345–355.
   PubMed Web of Science ®Google Scholar
• Stephens OM, Haudenschild BL, Beal PA. 2004. The binding selectivity of ADAR2's dsRBMs contributes to RNA-editing selectivity. Chem Biol. 11:1239–1250.
   PubMedGoogle Scholar
• Stephens OM, Yi-Brunozzi HY, Beal PA. 2000. Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site. Biochemistry. 39:12243–12251.
   PubMed Web of Science ®Google Scholar
• Strehblow A, Hallegger M, Jantsch MF. 2002. Nucleocytoplasmic distribution of human RNA-editing enzyme ADAR1 is modulated by double-stranded RNA-binding domains, a leucine-rich export signal, and a putative dimerization domain. Mol Biol Cell. 13:3822–3835.
   PubMed Web of Science ®Google Scholar
• Sugimoto Y, Vigilante A, Darbo E, Zirra A, Militti C, D'Ambrogio A, Luscombe NM, Ule J. 2015. hiCLIP reveals the in vivo atlas of mRNA secondary structures recognized by Staufen 1. Nature. 519:491–494.
   PubMed Web of Science ®Google Scholar
• Tabara H, Yigit E, Siomi H, Mello CC. 2002. The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans. Cell. 109(7):861–871.
   PubMed Web of Science ®Google Scholar
• Tajaddod M, Jantsch MF, Licht K. 2016. The dynamic epitranscriptome: A to I editing modulates genetic information. Chromosoma. 125:51–63.
   PubMed Web of Science ®Google Scholar
• Tang SJ, Shen H, An O, Hong H, Li J, Song Y, Han J, Tay DJT, Ng VHE, Bellido Molias F, et al. 2020. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development. Nat Commun. 11:799.
   PubMed Web of Science ®Google Scholar
• Tang ZL, Wang S, Tu C, Wang T, Ma CW, Liu Y, Xiao SX, Wang XP. 2018. Eight novel mutations of the ADAR1 gene in Chinese patients with Dyschromatosis Symmetrica Hereditaria. Genet Test Mol Biomarkers. 22(2):104–108.
   PubMed Web of Science ®Google Scholar
• Teoh PJ, An O, Chung TH, Chooi JY, Toh SHM, Fan S, Wang W, Koh BTH, Fullwood MJ, Ooi MG, et al. 2018. Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood. 132(12):1304–1317.
   PubMed Web of Science ®Google Scholar
• Thomas JM, Beal PA. 2017. How do ADARs bind RNA? New protein-RNA structures illuminate substrate recognition by the RNA editing ADARs. Bioessays. 39(4):1600187.
   Web of Science ®Google Scholar
• Thuy-Boun AS, Thomas JM, Grajo HL, Palumbo CM, Park S, Nguyen LT, Fisher AJ, Beal PA. 2020. Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition. Nucleic Acids Res.
   PubMed Web of Science ®Google Scholar
• Tomaselli S, Galeano F, Alon S, Raho S, Galardi S, Polito VA, Presutti C, Vincenti S, Eisenberg E, Locatelli F, et al. 2015. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma. Genome Biol. 16:5.
   PubMed Web of Science ®Google Scholar
• Tonkin LA, Saccomanno L, Morse DP, Brodigan T, Krause M, Bass BL. 2002. RNA editing by ADARs is important for normal behavior in Caenorhabditis elegans. Embo J. 21:6025–6035.
   PubMed Web of Science ®Google Scholar
• Valente L, Nishikura K. 2007. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J Biol Chem. 282:16054–16061.
   PubMed Web of Science ®Google Scholar
• Vallecillo-Viejo IC, Liscovitch-Brauer N, Montiel-Gonzalez MF, Eisenberg E, Rosenthal JJC. 2018. Abundant off-target edits from site-directed RNA editing can be reduced by nuclear localization of the editing enzyme. RNA Biol. 15:104–114.
   PubMed Web of Science ®Google Scholar
• Velazquez-Torres G, Shoshan E, Ivan C, Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C, Xie V, Brooks D, et al. 2018. A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression. Nat Commun. 9(1):461.
   PubMed Web of Science ®Google Scholar
• Vik ES, Nawaz MS, Strøm Andersen P, Fladeby C, Bjørås M, Dalhus B, Alseth I. 2013. Endonuclease V cleaves at inosines in RNA. Nat Commun. 4:2271.
   PubMed Web of Science ®Google Scholar
• Vitali P, Scadden AD. 2010. Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis. Nat Struct Mol Biol. 17:1043–1050.
   PubMed Web of Science ®Google Scholar
• Wahlstedt H, Ohman M. 2011. Site-selective versus promiscuous A-to-I editing. Wiley Interdiscip Rev RNA. 2:761–771.
   PubMed Web of Science ®Google Scholar
• Walkley CR, Li JB. 2017. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs. Genome Biol. 18:205.
   PubMed Web of Science ®Google Scholar
• Wang P, Yu S, Liu J, Zhang D, Kang X. 2019. Seven novel mutations of ADAR in multi-ethnic pedigrees with Dyschromatosis symmetrica hereditaria in China. Mol Genet Genomic Med. 7:e00905.
   PubMed Web of Science ®Google Scholar
• Wang Q, Hui H, Guo Z, Zhang W, Hu Y, He T, Tai Y, Peng P, Wang L. 2013. ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding. RNA. 19:1525–1536.
   PubMedGoogle Scholar
• Wang Q, Miyakoda M, Yang W, Khillan J, Stachura DL, Weiss MJ, Nishikura K. 2004. Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene. J Biol Chem. 279:4952–4961.
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Z, Blackwell K, Carmichael GG. 2005. Vigilins bind to promiscuously A-to-I-edited RNAs and are involved in the formation of heterochromatin. Curr Biol. 15:384–391.
   PubMed Web of Science ®Google Scholar
• Wang R, Zhang S, Chen X, Li N, Li J, Jia R, Pan Y, Liang H. 2018. CircNT5E acts as a sponge of miR-422a to promote glioblastoma tumorigenesis. Cancer Res. 78:4812–4825.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chung DH, Monteleone LR, Li J, Chiang Y, Toney MD, Beal PA. 2019. RNA binding candidates for human ADAR3 from substrates of a gain of function mutant expressed in neuronal cells. Nucleic Acids Res. 47:10801–10814.
   PubMed Web of Science ®Google Scholar
• Wang Y, Park S, Beal PA. 2018. Selective recognition of RNA substrates by ADAR deaminase domains. Biochemistry. 57:1640–1651.
   PubMed Web of Science ®Google Scholar
• Wang Y, Xu X, Yu S, Jeong KJ, Zhou Z, Han L, Tsang YH, Li J, Chen H, Mangala LS, et al. 2017. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Genome Res. 27:1112–1125.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng Y, Beal PA. 2017. Adenosine deaminases that act on RNA (ADARs). Enzymes. 41:215–268.
   PubMedGoogle Scholar
• Ward SV, George CX, Welch MJ, Liou LY, Hahm B, Lewicki H, de la Torre JC, Samuel CE, Oldstone MB. 2011. RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. Proc Natl Acad Sci USA. 108:331–336.
   PubMed Web of Science ®Google Scholar
• Warf MB, Shepherd BA, Johnson WE, Bass BL. 2012. Effects of ADARs on small RNA processing pathways in C. elegans. Genome Res. 22:1488–1498.
   PubMed Web of Science ®Google Scholar
• Washburn MC, Hundley HA. 2016. Trans and cis factors affecting A-to-I RNA editing efficiency of a noncoding editing target in C. elegans. RNA. 22:722–728.
   PubMed Web of Science ®Google Scholar
• Washburn MC, Kakaradov B, Sundararaman B, Wheeler E, Hoon S, Yeo GW, Hundley HA. 2014. The dsRBP and inactive editor ADR-1 utilizes dsRNA binding to regulate A-to-I RNA editing across the C. elegans transcriptome. Cell Rep. 6:599–607.
   PubMed Web of Science ®Google Scholar
• Weber F, Wagner V, Rasmussen SB, Hartmann R, Paludan SR. 2006. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol. 80:5059–5064.
   PubMed Web of Science ®Google Scholar
• Wettengel J, Reautschnig P, Geisler S, Kahle PJ, Stafforst T. 2017. Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res. 45:2797–2808.
   PubMed Web of Science ®Google Scholar
• Wheeler EC, Washburn MC, Major F, Rusch DB, Hundley HA. 2015. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript. RNA Biol. 12:162–174.
   PubMed Web of Science ®Google Scholar
• Wolozin B, Ivanov P. 2019. Stress granules and neurodegeneration. Nat Rev Neurosci. 20:649–666.
   PubMed Web of Science ®Google Scholar
• Woolf TM, Chase JM, Stinchcomb DT. 1995. Toward the therapeutic editing of mutated RNA sequences. Proc Natl Acad Sci U S A. 92:8298–8302.
   PubMed Web of Science ®Google Scholar
• Xing Q, Wang M, Chen X, Qian X, Qin W, Gao J, Wu S, Gao R, Feng G, He L. 2005. Identification of a novel ADAR mutation in a Chinese family with dyschromatosis symmetrica hereditaria (DSH). Arch Dermatol Res. 297:139–142.
   PubMed Web of Science ®Google Scholar
• Xu X, Wang Y, Mojumdar K, Zhou Z, Jeong KJ, Mangala LS, Yu S, Tsang YH, Rodriguez-Aguayo C, Lu Y, et al. 2019. A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis. J Clin Invest. 129:5343–5356.
   PubMed Web of Science ®Google Scholar
• Yang CC, Chen YT, Chang YF, Liu H, Kuo YP, Shih CT, Liao WC, Chen HW, Tsai WS, Tan BC. 2017. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response. Cell Death Dis. 8:e2833.
   PubMed Web of Science ®Google Scholar
• Yang S, Deng P, Zhu Z, Zhu J, Wang G, Zhang L, Chen AF, Wang T, Sarkar SN, Billiar TR, et al. 2014. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs. J Immunol. 193:3436–3445.
   PubMed Web of Science ®Google Scholar
• Yang W, Chendrimada TP, Wang Q, Higuchi M, Seeburg PH, Shiekhattar R, Nishikura K. 2006. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol. 13:13–21.
   PubMed Web of Science ®Google Scholar
• Zhang M, Fritsche J, Roszik J, Williams LJ, Peng X, Chiu Y, Tsou CC, Hoffgaard F, Goldfinger V, Schoor O, et al. 2018. RNA editing derived epitopes function as cancer antigens to elicit immune responses. Nat Commun. 9:3919.
   PubMed Web of Science ®Google Scholar
• Zhang XJ, He PP, Li M, He CD, Yan KL, Cui Y, Yang S, Zhang KY, Gao M, Chen JJ, et al. 2004. Seven novel mutations of the ADAR gene in Chinese families and sporadic patients with dyschromatosis symmetrica hereditaria (DSH). Hum Mutat. 23:629–630.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang K, Zhao Z, Sun S, Zhang K, Huang R, Zeng F, Hu H. 2018. ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R). Cancer Cell Int. 18:196.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Carmichael GG. 2001. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell. 106:465–475.
   PubMed Web of Science ®Google Scholar